BI-RADS category 4 means your mammogram, ultrasound, or breast MRI found something suspicious enough to warrant a biopsy. The category covers a wide range of cancer likelihood, from 2% to 95%, which is why it’s broken into three subcategories that give you a much clearer picture of your actual risk. The standard recommendation for any category 4 finding is tissue sampling, typically through a needle biopsy.
What the BI-RADS Scale Means
BI-RADS stands for Breast Imaging Reporting and Data System, a standardized scoring system created by the American College of Radiology. Radiologists use it to give every breast imaging study a score from 0 to 6, with each number carrying a specific management recommendation. Categories 1 and 2 are normal or clearly benign. Category 3 is probably benign and calls for a short follow-up scan. Categories 4 and 5 both trigger a biopsy recommendation, with category 5 reserved for findings that are almost certainly cancer (95% or higher likelihood). Category 4 fills the enormous middle ground between “probably fine” and “almost certainly malignant.”
The most recent version of the system, BI-RADS v2025, is an extension of the 5th Edition Atlas published in 2013 and remains the current standard for how radiologists report breast findings.
The Three Subcategories of BI-RADS 4
Because a 2% to 95% range isn’t very helpful on its own, category 4 is divided into three subcategories. Each one narrows the estimate considerably:
- 4A (low suspicion): 2% to 10% likelihood of cancer. This is the most common subcategory and includes findings that look mildly concerning but are expected to be benign after biopsy.
- 4B (moderate suspicion): 10% to 50% likelihood of cancer. Findings here don’t clearly fit either the benign or malignant pattern.
- 4C (high suspicion): 50% to just under 95% likelihood of cancer. These findings look worrisome but fall short of the near-certainty required for category 5.
The management recommendation is the same for all three: biopsy. But the subcategory tells you and your care team how aggressively to interpret the results. A 4A finding that comes back benign on biopsy is reassuring and expected. A 4C finding that comes back benign may prompt closer scrutiny of whether the biopsy sampled the right area.
Most Category 4 Biopsies Come Back Benign
If you’ve just received a category 4 result, the statistics may offer some reassurance. In a study of 186 biopsied category 4 lesions, 61% turned out to be benign and about 39% were malignant. The breakdown by subcategory tells a more useful story: roughly 71% of 4A lesions were benign, about 62% of 4B lesions were benign, and around 31% of 4C lesions were benign.
Common benign conditions that trigger a category 4 rating include fibroadenomas (solid, rubbery lumps made of breast tissue), fibrocystic changes, granulomatous mastitis (an inflammatory condition), and benign phyllodes tumors. These can all create imaging patterns that overlap with cancer, which is exactly why a biopsy is needed to tell them apart.
What Triggers a Category 4 Rating
Radiologists assign category 4 based on specific visual features in your imaging. A mass with irregular or indistinct margins raises more concern than one with smooth, well-defined edges. Calcifications, tiny calcium deposits that show up as white specks on a mammogram, matter too. Amorphous calcifications (small, hazy, hard-to-characterize deposits) carry roughly a 9% to 20% chance of malignancy, placing them in the 4A or 4B range depending on their distribution.
On ultrasound, features that suggest a benign finding include an oval shape, smooth borders, and an orientation parallel to the skin surface. Findings that lack these reassuring features get pushed into higher subcategories. The radiologist weighs all of these characteristics together, not just one feature in isolation, to arrive at the final score.
What Happens After a Category 4 Result
The next step is a biopsy, and it usually happens faster than people expect. On average, patients are biopsied within about 6 business days of their diagnostic imaging. Most facilities schedule within 9 days, and some high-performing centers offer same-day biopsy. Over the past 15 years, wait times have dropped by about 30%, so delays are less common than they used to be.
The most common procedure is a core needle biopsy, where a hollow needle removes small cylinders of tissue from the suspicious area. It’s done with local anesthesia, usually guided by ultrasound or mammography so the radiologist can see exactly where the needle is going. The procedure itself typically takes 15 to 30 minutes. A surgical biopsy (sometimes called a lumpectomy or open biopsy) is less common and usually reserved for cases where a needle biopsy isn’t feasible or didn’t provide a clear answer.
Pathology results from a core needle biopsy generally come back within a few business days, though the timeline varies by facility. Your results will either confirm a benign condition, identify cancer, or occasionally return as “atypical,” meaning the cells aren’t normal but aren’t clearly cancerous. Atypical results sometimes lead to a follow-up surgical biopsy to get a larger tissue sample.
What Your Subcategory Means for You
If your report says 4A, the odds are strongly in your favor. Most 4A findings are benign, and the biopsy is a precaution to rule out the small chance of cancer. You can think of it as the radiologist saying, “This is probably nothing, but I can’t be sure enough to skip the biopsy.”
A 4B result sits in genuine uncertainty. The finding could go either way, and the biopsy is essential for getting a clear answer. A 4C result means the radiologist is fairly concerned, though even here, roughly one in three findings turns out to be noncancerous. Regardless of subcategory, the biopsy is what converts uncertainty into a definitive answer, and it’s the fastest path to either relief or a treatment plan.